A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer

NCT06011291 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
Head and Neck Cancer

Interventions

DRUG: SYH2051 tablets
RADIATION: Intensity-Modulated Radiation Therapy (IMRT)

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.